Menu Search
Equities

Grand Brilliance Group Holdings Ltd

8372:HKG.HZ

Grand Brilliance Group Holdings Ltd

Actions
  • Price (HKD)0.11
  • Today's Change0.004 / 3.77%
  • Shares traded120.00k
  • 1 Year change+52.78%
  • Beta--
Data delayed at least 15 minutes, as of May 10 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Grand Brilliance Group Holdings Limited is an investment holding company mainly engaged in the distribution of medical devices. The Company also provides medical device solutions, including market trend analysis, sourcing of medical devices, after-sale services, technical support and training services, medical device leasing services and quality assurance. Its medical device products include medical consumables, medical equipments, medical instruments and other healthcare products which are ancillary in nature. The medical consumables include needleless connectors, ligation clips, biopsy needles, drapes used during operation, suction liners, suction tubings, wound drain products, respiratory and feeding products, among others. The medical equipments include electric beds and mattresses, stretchers, furniture used in wards, respiratory care products and blood warmers, among others.

  • Revenue in HKD (TTM)84.98m
  • Net income in HKD7.86m
  • Incorporated2017
  • Employees44.00
  • Location
    Grand Brilliance Group Holdings LtdUnits 2901-2903 and 2905, 29/F, The Octa6 Sha Tsui Road, Tsuen Wan, New Territo Hong KongHKG
  • Phone+852 24250926
  • Fax+852 24239092
  • Websitehttp://www.grandbrilliancegroup.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.